We are live on ! Find out more
PCM

Pathway Capital Management Portfolio holdings

AUM $4.3M
1-Year Est. Return 62.8%
This Fund
S&P 500
This Quarter Est. Return
+15.57%
1 Year Est. Return
+62.8%
3 Year Est. Return
+496.35%
5 Year Est. Return
+305.57%
10 Year Est. Return
–
AUM
$18M
AUM Growth
+$16.8M
Cap. Flow
+$18.6M
Cap. Flow %
102.97%
Top 10 Hldgs %
100%
Holding
7
New
5
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
RBLX icon
Roblox
RBLX
+$9.13M
2
BEAM icon
Beam Therapeutics
BEAM
+$3.56M
3
QTRX icon
Quanterix
QTRX
+$3.42M
4
VIR icon
Vir Biotechnology
VIR
+$2.55M
5
PDD icon
Pinduoduo
PDD
+$870K

Top Sells

Rank Stock Value
1
MRSN
Mersana Therapeutics
MRSN
+$1.08M

Sector Composition

Rank Sector Weight
1 Healthcare 49.09%
2 Communication Services 47.09%
3 Consumer Discretionary 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RBLX icon
1
Roblox
RBLX
$37B
$8.49M 47.09%
+131,036
New +$9.13M
QTRX icon
2
Quanterix
QTRX
$182M
$3.21M 17.81%
54,946
+50,646
+1,178% +$3.42M
BEAM icon
3
Beam Therapeutics
BEAM
$2.83B
$2.99M 16.59%
+37,399
New +$3.56M
VIR icon
4
Vir Biotechnology
VIR
$1.59B
$2.42M 13.43%
+47,255
New +$2.55M
PDD icon
5
Pinduoduo
PDD
$120B
$690K 3.82%
+5,151
New +$870K
RUBY
6
DELISTED
Rubius Therapeutics, Inc
RUBY
$227K 1.26%
+8,562
New +$125K
MRSN
7
DELISTED
Mersana Therapeutics
MRSN
– –
-1,624
Closed -$1.08M

Similar funds

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
KAM
Kirkoswald Asset Management New York $5.23M AUM
FWA
FSC Wealth Advisors Fishkill, New York $5.24M AUM 17.32% 1-Year Est. Return
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return

Pathway Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Pathway Capital Management held 7 positions worth $18M, up 1,309% from $1.28M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pathway Capital Management deployed $18.6M of net new capital in Q1 2021, opening 5 new positions and adding to 1 existing holding. Its largest new stake was Roblox: 131,036 shares worth $8.49M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 100% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the most notable exit was Mersana Therapeutics, an estimated $1.08M sold.

  • Pathway Capital Management's largest Q1 2021 buy was Roblox: 131,036 shares worth $8.49M.
  • Pathway Capital Management added most to Quanterix in Q1 2021, an estimated $3.42M increase.
  • Pathway Capital Management fully exited Mersana Therapeutics in Q1 2021, selling an estimated $1.08M.
  • Pathway Capital Management's ten largest holdings make up 100% of its $18M portfolio in Q1 2021.
  • Pathway Capital Management opened 5 new positions and closed 1 in Q1 2021.
  • Pathway Capital Management's portfolio value rose 1,309% quarter-over-quarter to $18M.

Based on Pathway Capital Management's 13F filing for Q1 2021, filed 13 May 2021.